Literature DB >> 11754005

Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes.

Massimo Triggiani1, Francescopaolo Granata, Alfonso Oriente, Marco Gentile, Angelica Petraroli, Barbara Balestrieri, Gianni Marone.   

Abstract

Secretory phospholipases A2 (sPLA2) are released in the blood of patients with various inflammatory diseases and exert proinflammatory activities by releasing arachidonic acid (AA), the precursor of eicosanoids. We examined the ability of four sPLA2 to activate blood and synovial fluid monocytes in vitro. Monocytes were purified from blood of healthy donors or from synovial fluid of patients with rheumatoid arthritis by negative immunoselection and by adherence to plastic dishes, respectively. The cells were incubated with group IA, IB, IIA and III sPLA2 and the release of TNF-alpha, IL-6 and IL-12 was determined by ELISA. Group IA, IB and IIA sPLA2 induced a concentration-dependent release of TNF-alpha and IL-6 from blood monocytes. These sPLA2 activated IL-12 production only in monocytes preincubated with IFN-gamma. Group IA and IIA sPLA2 also induced TNF-alpha and IL-6 release from synovial fluid monocytes. TNF-alpha and IL-6 release paralleled an increase in their mRNA expression and was independent from the capacity of sPLA2 to mobilize AA. These results indicate that sPLA2 stimulate cytokine release from blood and synovial fluid monocytes by a mechanism at least partially unrelated to their enzymatic activity. This effect may concur with the generation of AA in the proinflammatory activity of sPLA2 released during inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754005     DOI: 10.1002/1521-4141(200201)32:1<67::AID-IMMU67>3.0.CO;2-3

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.

Authors:  Aleksandra A Korotaeva; Elena V Samoilova; Aleksander I Kaminny; Aleksandra A Pirkova; Therese J Resink; Paul Erne; Nina V Prokazova; Vsevolod A Tkachuk; Evgeny I Chazov
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

2.  Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses.

Authors:  Mathanraj Packiam; Sandra J Veit; Deborah J Anderson; Robin R Ingalls; Ann E Jerse
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

3.  Secretory phospholipase A2 induces dendritic cell maturation.

Authors:  Laure Perrin-Cocon; Sophie Agaugué; Frédéric Coutant; Aurélie Masurel; Sofiane Bezzine; Gérard Lambeau; Patrice André; Vincent Lotteau
Journal:  Eur J Immunol       Date:  2004-08       Impact factor: 5.532

4.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

5.  Comparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis.

Authors:  Liam G Coulthard; Jaclyn Costello; Brent Robinson; Ian A Shiels; Stephen M Taylor; Trent M Woodruff
Journal:  Arthritis Res Ther       Date:  2011-03-14       Impact factor: 5.156

6.  Plasma Phospholipids: A Promising Simple Biochemical Parameter to Evaluate COVID-19 Infection Severity.

Authors:  Mohammed Abdalla Hussein; Noor Eldin Mohamed Ismail; Ahmed H Mohamed; Rita M Borik; Ali Abdelaziz Ali; Yasser O Mosaad
Journal:  Bioinform Biol Insights       Date:  2021-11-18

7.  Phenotypic and Functional Heterogeneity of Low-Density and High-Density Human Lung Macrophages.

Authors:  Barbara Balestrieri; Francescopaolo Granata; Stefania Loffredo; Angelica Petraroli; Giulia Scalia; Paolo Morabito; Chiara Cardamone; Gilda Varricchi; Massimo Triggiani
Journal:  Biomedicines       Date:  2021-05-04

8.  Effect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural study.

Authors:  Maung-Maung Thwin; Eleni Douni; Vassilis Aidinis; George Kollias; Kyoko Kodama; Kazuki Sato; Ramapatna L Satish; Ratha Mahendran; Ponnampalam Gopalakrishnakone
Journal:  Arthritis Res Ther       Date:  2004-04-28       Impact factor: 5.156

9.  Modulation of the pharmacological effects of enzymatically-active PLA2 by BTL-2, an isolectin isolated from the Bryothamnion triquetrum red alga.

Authors:  Simone Cb Oliveira; Fabiana V Fonseca; Edson Antunes; Enilton A Camargo; Rafael P Morganti; Ricardo Aparício; Daniela O Toyama; Luís Os Beriam; Eudismar V Nunes; Benildo S Cavada; Celso S Nagano; Alexandre H Sampaio; Kyria S Nascimento; Marcos H Toyama
Journal:  BMC Biochem       Date:  2008-06-06       Impact factor: 4.059

Review 10.  Citicoline and COVID-19-Related Cognitive and Other Neurologic Complications.

Authors:  Yuda Turana; Michael Nathaniel; Robert Shen; Soegianto Ali; Rajender R Aparasu
Journal:  Brain Sci       Date:  2021-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.